Supply chain, logistics

update

Fabbrica Italiana Sintetici Expands IMCD Promotion Deal

26-Aug-2013

IMCD Group will promote APIs made by Italian firm FIS in territories in Eastern Europe and the Southern hemisphere under a new agreement. 

More CROs Using Loyalty Bonuses in Global "War for Talent"

19-Aug-2013 By Zachary Brennan

Globalization and high demand are prompting more CROs to add bonuses to retain and acquire talent.

TransCelerate Aims to Ease Trial Comparator Sourcing

19-Aug-2013 By Zachary Brennan

The TransCelerate BioPharma industry group has launched its clinical trial comparator network to establish a reliable means for sourcing quality drugs for clinical trials. 

Electronic Informed Consent: Will it Increase Patient Knowledge on Trials?

13-Aug-2013 By Zachary Brennan

As the modernization of the informed consent process looks to keep patients better informed with electronic presentations of trial information, sponsors and CRO may also utilize the tech to track more data. 

Marken Expands Kit-Building Ops in Singapore to Meet Client Demand

13-Aug-2013 By Zachary Brennan

Due to growing client demand, Marken will expand its kit-building operations in Singapore to increase production by about 10,000 kits per month.

Vindon Opens Pharma Storage Site in California

13-Aug-2013 By Dan Stanton

Vindon has opened the doors of a new US biopharmaceutical storage facility to service Californian and West Coast drug firms.

Covance Launches New Contract Service for Biopharma, Med Device Clients

08-Aug-2013 By Zachary Brennan

CRO Covance is looking to help its biopharmaceutical and medical device clients manage their contract terms and associated payments better as some companies are losing almost 5% of US revenue from insufficient processes and contract management systems.

PTI to Expand Missouri Manufacturing Facility with $5M Investment

08-Aug-2013 By Zachary Brennan

CMO Pharma Tech Industries (PTI) will invest more than $5M to expand its production facility in Union, Missouri, which makes ingestible powders.

Charles River’s Q2 Buoyed by RMS Division, Recent Acquisitions

06-Aug-2013

CRO Charles River Laboratories saw slight growth in Q2 thanks to its Research Models & Services (RMS) division and two recent acquisitions.

Quintiles Posts Strong Quarterly Growth as Bookings Flatten Slightly

05-Aug-2013 By Zachary Brennan

CRO Quintiles last week announced its fourth consecutive quarter of at least $1B in net new business, as well as 13% growth in the second quarter of this year, though analysts said the company did not meet bookings expectations.

Consistent Trial Site Payments Key to Long-Term Relationships with Investigators

25-Jul-2013 By Zachary Brennan

The days of using Excel spreadsheets to manage clinical trial site payments are now in the past, especially as CROs and sponsors look to retain their most highly-prized sites and establish long-term relationships for future trials.

Corgenix Wins Contract to Manufacture EDP’s Colon Cancer Diagnostic

15-Jul-2013 By Zachary Brennan

Over the next 10 years CMO Corgenix will contract manufacture EDP Biotech’s diagnostic test to detect the early stages of colon cancer, the companies agreed last week.

Big Pharma Begins Mutually Recognizing GCP Training, Site Qualifications

15-Jul-2013 By Zachary Brennan

Big Pharma members of industry group TransCelerate are developing a mutual recognition plan for site GCP assessments and investigator training.

Theft Down Since $80m Lilly Heist as Industry Shares Intelligence

03-Jul-2013 By Dan Stanton

Collaboration and intelligence sharing has seen pharmaceutical cargo theft decline heavily since Lilly fell prey to an $80m heist in 2010, says industry expert.

Trial Site Feasibility Platform Looks to End Onerous Paper Questionnaires

03-Jul-2013 By Zachary Brennan

The antiquated process of evaluating clinical trial sites through paper questionnaires may be coming to an end thanks to a new online platform.

Pharma Abandoning East, Returning West for CMOs say GPCM Delegates

02-Jul-2013 By Dan Stanton

Pharma firms are returning to European and North American manufacturers as quality issues and rising costs have lost India and China some of its ‘Eastern promise,’ according to industry experts.

UPDATE

Industrial Action Halts Operations at Indian CMO Shasun Facility

18-Jun-2013 By Dan Stanton

Shasun Pharmaceuticals’ says it is trying to restart operations at the earliest opportunity after workers went on strike at its API and formulation facility in India last Sunday.

CROs Forge Imaging Partnership to Meet Biopharma Industry Need

18-Jun-2013 By Zachary Brennan

MPI Research, inviCRO and 3D Imaging are partnering to combine their imaging tools at a new center in Michigan aimed at large biopharma clients.

DHL Launches Cold Chain Air Distribution Service

17-Jun-2013 By Dan Stanton

Logistics company DHL has launched a new temperature controlled air freight service to service for biologics.

Patheon Sees Revenue Increase in Q2 as CMO Business Thrives

13-Jun-2013 By Zachary Brennan

Canadian CMO Patheon’s second quarter revenues increased almost 40 percent as the company’s commercial manufacturing services revenues saw a similarly high rise over the same period from last year.

AstraZeneca Selects IT Contractor for Three Neuroscience Trials

11-Jun-2013 By Zachary Brennan

AstraZeneca has chosen ePharmaSolutions to provide IT services for three separate neuroscience trials.

UPS Opens Second China Site to Support Growing Healthcare Market

04-Jun-2013 By Dan Stanton

The ever-expanding market in China has plenty of room for 3rd party pharmaceutical distribution and logistics companies says UPS as it opens a new facility in Zhejiang Province.

Unither Acquires UCB Manufacturing, Packaging Plant in New York

04-Jun-2013 By Zachary Brennan

Unither has agreed to acquire UCB’s manufacturing and packaging facility in Rochester, New York, and will produce UCB products at the site.

Lilly Adds Another to List of Companion Diagnostic Contractors

29-May-2013 By Zachary Brennan

Eli Lilly has selected another contractor to help develop companion diagnostics for its oncology pipeline.

Update

CROs, Sponsors Look to Service Providers to Comply with US Sunshine Act

23-May-2013 By Zachary Brennan

As CROs and pharmaceutical sponsors must begin collecting data in August to comply with the Sunshine Act, some companies are now looking to service providers for help. 

Dispatches from Interphex

TFS Sees Increase in Modularization, Shorter Construction Timelines

21-May-2013

Biopharma companies are looking for more pre-fabrication of their facilities and to be able to expedite construction and meet tighter timelines, an expert told Outsourcing-Pharma.com.

Yusen to Fly AstraZeneca's Drugs to Australia

15-May-2013

Yusen Logistics has launched a new air freight service to help UK drug major AstraZeneca ship its products to Australia in a new agreement announced today.

Wuxi Manufacturing Services Help Increase Quarterly Earnings

15-May-2013 By Zachary Brennan

Better than expected growth in Wuxi’s manufacturing services has driven the CRO to exceed its earlier guidance in the first quarter of 2013.

McKesson Confident FY2014 Will See Revenue Growth

13-May-2013 By Dan Stanton

Brand-to-generic conversions have been blamed for “somewhat softer than expected” financial results at McKesson, though significant FY2014 direct revenue growth has been predicted.

Ohio District Court Ruling Against Medpace Could Set Bar for MSAs

30-Apr-2013 By Zachary Brennan

With a ruling that could have implications for any CRO looking to understand its rights under a MSA (master services agreement) with a sponsor, a federal district court in Ohio has ruled against CRO Medpace.

Lonza Closes Ireland Site as US Manufacturing Issues Cause Increlex Shortage

30-Apr-2013 By Zachary Brennan

Manufacturing disruptions at Lonza's Hopkinton, Massachusetts site are causing shortages of Ipsen Biopharmaceuticals’ growth failure treatment for children in both the US and EU, just as the company announces that it will shutter another manufacturing...

'Many Moving Parts' Subdue AmerisourceBergen's Q2 Results

29-Apr-2013 By Dan Stanton

In a quarter that has seen the company divest its contract packaging and Canadian drug distribution arms, AmerisourceBergen’s Q2 results have been deemed “less than special” by analysts.

AstraZeneca Cooperating with Manufacturing Questions from US DOJ District Attorney

29-Apr-2013 By Zachary Brennan

The US Department of Justice’s Attorney’s Office in Boston has sent subpoenaed documents related to AstraZeneca's UK manufacturing practices, which the company said it is complying with. 

US Congress Needs to Establish Firm T&T Timeline, Standards, Stakeholders Say

29-Apr-2013 By Zachary Brennan

A clear timeline and stepwise approach to a US solution for tracking and tracing pharmaceuticals through the supply chain to root out counterfeits is necessary, stakeholders agreed.

DKSH Ups Asian Distribution Services; Sanofi Invests In-House in Africa

22-Apr-2013 By Dan Stanton

DKSH has upgraded its cold chain infrastructure in Southeast Asia as both small and large manufacturers increase their access needs to emerging markets.

Allergan CMO Issues Prompt US FDA to Reject Migraine Drug Again

18-Apr-2013 By Zachary Brennan

US regulators have rejected Allergan's candidate migraine drug Levadex for a second time, this time citing concerns about the CMO - Exemplar Pharma - the Californian drugmaker acquired earlier in the week for $20m.

GSK’s Contract Manufacturing Delays Cause Shortage of Restless Leg Treatment

18-Apr-2013 By Zachary Brennan

GlaxoSmithKline’s contract manufacturer has experienced unspecified manufacturing issues that are expected to set back supplies of its restless leg treatment Horizant until June. 

DKSH Bags Pfizer Deal in Cambodia

17-Apr-2013 By Gareth Macdonald

DKSH has won a second deal with a Big Pharma firmin Asia in as many months, with US giant Pfizer signing up the firm as its agent in Cambodia.

DHL: Globalisation, Generics & Biologics Drive Cold Chain Expansion

17-Apr-2013 By Dan Stanton

Globalisation, outsourcing and a move towards biopharmaceuticals are leading innovation for pharma distribution companies, according to DHL Global Forwarding.

Tech Innovation in Packaging Can Compete with Insourcing, says Frazier

11-Apr-2013 By Dan Stanton

Following recent acquisitions in the contract packaging industry, Frazier Healthcare says it can compete against insourcing and will lead innovation by focusing on serialization and new technologies.

Africa in Sight as Yusen Enhances its Contract Distribution Footprint

09-Apr-2013 By Dan Stanton

Yusen Logistics says Africa is “a major target area” as it develops its healthcare distribution services.

Janssen Releases Additional Doxil Lot via Alternative Manufacturing Approach

09-Apr-2013 By Zachary Brennan

The US FDA has cleared Janssen to release one Lot of Doxil made using an unapproved manufacturing process at Ben Venue's plant to help alleviate shortages.

Vetter to Begin GMP Filling Following Full Validation

08-Apr-2013 By Dan Stanton

Vetter says demand for prefilled-syringes will be accommodated by its newly approved commercial filling line.

Knipper Reaches Summit of Sample Management Business with InVentiv Purchase

08-Apr-2013 By Zachary Brennan

J. Knipper and Co. claims the acquisition of InVentiv Health’s sample management and fulfillment business makes it the largest manufacturer-to-physician drug sample services firm in the US.

GSK to Expand Supplier "Risk Mapping" in 2013

03-Apr-2013 By Gareth Macdonald

GSK will conduct more audits of key suppliers in 2013 as part of a ‘risk mapping’ effort to safeguard its £9bn ($13bn) a year outsourcing spend.

AmerisourceBergen Exits Contract Packaging and Canadian Distribution

03-Apr-2013 By Dan Stanton

AmerisourceBergen has sold AndersonBrecon for $308m, exiting the contract packaging business in order to concentrate on its core business.

Pfizer Manufacturing Issues Cause TB Injection Shortage, Discoloured Vials

27-Mar-2013 By Zachary Brennan

Pfizer’s Rifampin injections used to treat TB (tuberculosis) are in short supply as the company says manufacturing issues caused some vials and solutions of the drug to be possibly contaminated.

Contract Manufacturing Regulatory Approval Round-Up

26-Mar-2013 By Dan Stanton

Evonik gets the thumbs up from the MHRA, Recipharm's approved by Japan and Simcere passes the Chinese regulatory test – welcome to Outsourcing-Pharma’s round-up of GMP accreditation.

Update

Propofol Lethal Injections Blocked as Teva and Hospira Re-Enter Market

26-Mar-2013 By Dan Stanton

Both Teva and Hospira have pledged to restrict distribution of propofol as a lethal injection ingredient while production of the drug recommences.

DKSH's Cambodian Services Deal with Bayer Gets 5 Year Extension

21-Mar-2013 By Dan Stanton

DKSH says its contract extension with Bayer in Cambodia strengthens its position as a service provider for pharmaceutical companies throughout Southeast Asia.